BRA
PLSE icon

Bender Robert & Associates’s Pulse Biosciences PLSE Stock Holding History

Bender Robert & Associates’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$263K Buy
+12,190
New +$225K 0.06% 38
2025
Q4 		– Sell
-11,590
Closed -$205K – 44
2025
Q3 		$205K Hold
11,590
– – 0.04% 44
2025
Q2 		$175K Buy
+11,590
New +$192K 0.04% 46
2025
Q1 		– Sell
-11,590
Closed -$202K – 45
2024
Q4 		$202K Buy
+11,590
New +$204K 0.05% 43
2024
Q1 		– Sell
-10,325
Closed -$126K – 48
2023
Q4 		$126K Hold
10,325
– – 0.03% 48
2023
Q3 		$41.6K Hold
10,325
– – 0.01% 47
2023
Q2 		$74.2K Buy
+10,325
New +$66K 0.02% 48
2021
Q2 		– Sell
-8,825
Closed -$209K – 51
2021
Q1 		$209K Buy
+8,825
New +$264K 0.07% 53

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Bender Robert & Associates's PLSE Position: Q1 2026 in Review

Bender Robert & Associates opened a new position in Pulse Biosciences (PLSE) in Q1 2026: 12,190 shares worth $263K. The stake represents 0.06% of the portfolio and ranks #38 among its holdings. This is a return to the name: Bender Robert & Associates previously reported a position in PLSE as recently as Q3 2025.

Bender Robert & Associates first reported a position in PLSE in Q1 2021 and has held it in 8 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Bender Robert & Associates held 12,190 shares of Pulse Biosciences worth $263K as of Q1 2026.
  • Pulse Biosciences was a new Bender Robert & Associates position in Q1 2026.
  • Pulse Biosciences made up 0.06% of Bender Robert & Associates's portfolio in Q1 2026, its #38 holding.
  • Bender Robert & Associates first reported a position in Pulse Biosciences in Q1 2021 and has held it in 8 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Bender Robert & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.